APA (7th ed.) Citation

I, C., J, B., A, G., K, G., D, K., J, B., . . . M, M. (2024). Usage prevalence of angioedema patient-reported outcome measures: Results from the UCARE and ACARE PROMUSE study. The journal of allergy and clinical immunology. In practice, 12(8), 2211. https://doi.org/10.1016/j.jaip.2024.04.056

Chicago Style (17th ed.) Citation

I, Cherrez-Ojeda, et al. "Usage Prevalence of Angioedema Patient-reported Outcome Measures: Results from the UCARE and ACARE PROMUSE Study." The Journal of Allergy and Clinical Immunology. In Practice 12, no. 8 (2024): 2211. https://doi.org/10.1016/j.jaip.2024.04.056.

MLA (9th ed.) Citation

I, Cherrez-Ojeda, et al. "Usage Prevalence of Angioedema Patient-reported Outcome Measures: Results from the UCARE and ACARE PROMUSE Study." The Journal of Allergy and Clinical Immunology. In Practice, vol. 12, no. 8, 2024, p. 2211, https://doi.org/10.1016/j.jaip.2024.04.056.